A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/2002
12/19/2002	CA2447557A1 Using supercritical fluids to infuse therapeutic on a medical device
12/18/2002	EP1267171A1 Cofactor-based screening method for nuclear receptor modulators
12/18/2002	EP1266666A2 Fibrin sealant compositions and method for utilizing same
12/18/2002	EP1266012A2 Proteases
12/18/2002	EP1266006A2 Production of recombinant blood clotting factors in human cell lines
12/18/2002	EP1266001A2 Human transcription factors
12/18/2002	EP1266000A1 Chordin-like-2 molecules and uses thereof
12/18/2002	EP1265995A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression
12/18/2002	EP1265929A1 Anti-c2/c2a inhibitors of complement activation
12/18/2002	EP1265919A2 G-protein associated molecules
12/18/2002	EP1265905A1 Il-8 receptor antagonists
12/18/2002	EP1265900A1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
12/18/2002	EP1265899A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/18/2002	EP1265891A2 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
12/18/2002	EP1265867A1 Novel malonic acid derivates, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them
12/18/2002	EP1265860A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
12/18/2002	EP1265859A2 Amidino compounds useful as nitric oxide synthase inhibitors
12/18/2002	EP1265853A1 Carboxylic acid derivatives as ip antagonists
12/18/2002	EP1265840A2 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
12/18/2002	EP1265839A1 Compounds active at the glucocorticoid receptor
12/18/2002	EP1265648A1 Novel natural polymer-based material with improved properties for use in human and veterinary medicine and the method of manufacturing such
12/18/2002	EP1265639A1 The use of anticoagulant agents in the extracorporeal treatment of blood
12/18/2002	EP1265628A1 Use of human not1 and not1a orphan receptors
12/18/2002	EP1265603A2 Il-8 receptor antagonists
12/18/2002	EP1265596A2 Medical emulsion for lubrication and delivery of drugs
12/18/2002	EP1149096B1 Tricyclic pyridine n-oxides vasopressin agonists
12/18/2002	EP1124814B1 Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level
12/18/2002	EP0873309B1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
12/18/2002	EP0859784B1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation
12/18/2002	EP0859607B1 Guanidino protease inhibitors
12/18/2002	EP0789583B1 Methods and kits using macrophage stimulating protein
12/18/2002	CN1385532A Expression system utilizing self-schizolysis fusing protein and novel reduction polypeptide
12/18/2002	CN1385529A Expression system utilizing self-schizolysis fusing protein and novel reduction polypeptide
12/18/2002	CN1385417A Polyasparacyl-L-arginine, its preparation and medical application
12/18/2002	CN1385196A Multi-function health care food and application thereof
12/18/2002	CN1096461C Purine derivatives and their use as anti-coagulants
12/17/2002	US6495684 Inhibit human factor xa; treating diseases characterized by thrombotic activity; for example 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4-(2,3 -dihydroxypropoxy)pyridin-2-yl)oxy)-4-hydroxybenzamidine
12/17/2002	US6495608 Methods of performing surgery with galactomannan polymers and borate
12/17/2002	US6495590 Use of amtolmetin guacyl for the production of anti-inflammatory drugs for intestinal inflammations
12/17/2002	US6495582 Erk (extracellular signal regulated kinase) inhibitors for treatment of cancer, inflammatory disorders, restenosis, and cardiovascular disease
12/17/2002	US6495574 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
12/17/2002	US6495570 Combination drug therapy for glycolipid storage diseases
12/17/2002	US6495565 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition
12/17/2002	US6495560 10,11-dihydro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)-1 -ethoxy)-5h-dibenzo(a,d)cycloheptene-10-acetic acid; treatment of osteoporosis
12/17/2002	US6495559 For therapy of obesity
12/17/2002	US6495552 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid.
12/17/2002	US6495544 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase
12/17/2002	US6495518 Method for importing biologically active molecules into cells
12/17/2002	US6495516 Method for killing gram-negative bacteria with biologically active peptides from functional domains of bacterial/permeability-increasing protein
12/17/2002	US6495346 Do not react with foreign partners; amino acids inserted into proteins which naturally form dimers, mutated proteins only form complexes with themselves (homodimers) or with the mutated partner (heterodimers), not with nonmutated starting
12/17/2002	US6495165 Eplerenone compositions having improved bioavailability
12/14/2002	CA2390686A1 Cofactor-based screening method for nuclear receptor modulators and related modulators
12/13/2002	WO2001096575A1 Ceramide kinase and dna encoding the same
12/13/2002	CA2412876A1 Ceramide kinase and dna encoding the same
12/12/2002	WO2002099115A2 Nucleic acid-associated proteins
12/12/2002	WO2002099108A2 Atp-binding cassette transporter-like molecules and uses thereof
12/12/2002	WO2002098873A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	WO2002098871A1 Phenylcarboxamides and process for preparation thereof
12/12/2002	WO2002098869A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds
12/12/2002	WO2002098864A1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors
12/12/2002	WO2002098856A2 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists
12/12/2002	WO2002098839A1 Biphenylcarboxamides and process for preparation thereof
12/12/2002	WO2002098444A2 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
12/12/2002	WO2002098428A1 Tetracyclic compounds as pde5-inhibitors
12/12/2002	WO2002098422A1 Use of methylnaltrexone to treat immune suppression
12/12/2002	WO2002098362A2 Use of rank antagonists to treat cancer
12/12/2002	WO2002098348A2 Glp-1 formulations with protracted time action
12/12/2002	WO2002083879A3 Immunotherapy based on dendritic cells
12/12/2002	WO2002076977A3 Rho-kinase inhibitors
12/12/2002	WO2002076976A3 Rho-kinase inhibitors
12/12/2002	WO2002074798A3 The genome of a bifidobacterium
12/12/2002	WO2002072548A3 Heterocyclic compounds and their use as histamine h4 ligands.
12/12/2002	WO2002064552A8 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES
12/12/2002	WO2002062843A3 Modified erythropoietin (epo) with reduced immunogenicity
12/12/2002	WO2002062792A9 Jnk inhibitor
12/12/2002	WO2002059065A3 Oligo or polyalkylene glycol-coupled thrombin inhibitors
12/12/2002	WO2002053288A3 A method for the manufacture of compositions containing low concentrations of salts
12/12/2002	WO2001027303A9 Adeno-associated virus vectors encoding factor viii and methods of using the same
12/12/2002	US20020188122 Such as pyridine-4-carboxaldehyde-(4-Morpholinylprop-3-yl) imine for use in therapy as cytokine inhibitors
12/12/2002	US20020188018 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
12/12/2002	US20020187999 Anti-inflammatory uses of manzamines
12/12/2002	US20020187939 Use of inhibitors of the renin-angiotensin system
12/12/2002	US20020187933 Cardiovascular disorders; regeneration of heart tissue
12/12/2002	US20020187930 Substances and their uses
12/12/2002	US20020187102 Novel compositions for use in embolizing blood vessels
12/12/2002	CA2449658A1 Use of rank antagonists to treat cancer
12/12/2002	CA2449175A1 Use of methylnaltrexone to treat immune suppression
12/12/2002	CA2449109A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	CA2448606A1 Nucleic acid-associated proteins
12/12/2002	CA2448382A1 Use of hepcidin as a regulator of iron homeostasis
12/12/2002	CA2447935A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
12/12/2002	CA2430697A1 Atp-binding cassette transporter-like molecules and uses thereof
12/11/2002	EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002	EP1264599A1 TNF-derived peptides for use in treating oedema
12/11/2002	EP1264597A2 Methods and compositions for treating cancer
12/11/2002	EP1263960A2 Anti-tissue factor antibodies with enhanced anticoagulant potency
12/11/2002	EP1263959A1 Antibodies to human cd154
12/11/2002	EP1263943A1 Protein c derivatives
12/11/2002	EP1263803A1 Embolic compositions
12/11/2002	EP1263786A2 Methods and compositions for immunoregulation

1 ... 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 ... 671